TerminatedPhase 3ACTRN12606000085572
Dexmedetomidine and Haloperidol for the management of emergence delirium in intensive care
Sponsor
Prince of Wales Hospital
Enrollment
60 participants
Start Date
Mar 1, 2006
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 18 Yearss
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying: Dexmedetomidine and Haloperidol for the management of emergence delirium in intensive care. It may be open to adults aged 18 and older who meet certain criteria, including: Requiring invasive ventilation for longer than 24 hours. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will be randomised to receive IV Haloperidol 5 mg 6 hourly after loading
Patients will be randomised to receive IV Haloperidol 5 mg 6 hourly after loading
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12606000085572